Michael Lynes, Fulbright professor from University of Connecticut

From University of Connecticut, Department head and professor of molecular and cell biology Michael Lynes, is to conduct research at the Center for Diabetes Research at the University of Bergen, to explore the relevance of a therapeutic antibody he developed that can prevent the progression of Type 1 diabetes in mice, and whether it could effectively be used in treating patients.

For more information, see attachment:  MT and diabetes experimental questions Nov 2021.